Optimising prevention and vaccination policy for pneumococcal disease, influenza and RSV in Indigenous Australians

优化澳大利亚原住民肺炎球菌疾病、流感和呼吸道合胞病毒的预防和疫苗接种政策

• 批准号: nhmrc : 490340
• 负责人: A/Pr Susan Skull
• 金额: $ 11.66万
• 依托单位: Menzies School of Health Research
• 依托单位国家: 澳大利亚
• 项目类别: Early Career Fellowships
• 财政年份: 2008
• 资助国家: 澳大利亚
• 起止时间: 2008-01-01 至 2012-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/optimising-prevention-vaccination-indigenous-australians/115438
• 关键词: Optimising; prevention; vaccination; policy; pneumococcal

Despite recommending pneumococcal vaccine in the Northern Territory since 2000 for Indigenous Australians from 15 years of age, and increasing vaccination coverage, a corresponding reduction in disease has not been observed. This study will provide an evidence base for future vaccination policy by examining whether there is an adequate immune response to pneumococcal vaccination in Indigenous Australians, and whether prior vaccination could reduce the immune response to revaccination.

尽管自2000年以来，北领地建议15岁以上的澳大利亚土著居民接种肺炎球菌疫苗，并增加了疫苗接种覆盖率，但没有观察到疾病的相应减少。这项研究将为未来的疫苗接种政策提供证据基础，研究澳大利亚土著居民对肺炎球菌疫苗接种是否有足够的免疫反应，以及先前接种疫苗是否会降低对再次接种疫苗的免疫反应。